Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
SMS Pharmaceuticals Ltd.
Swot
SMS Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
SMS Pharmaceuticals Ltd. has 19 Strengths, 5 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(19)
Weakness
(5)
Opportunity
(3)
Threats
(1)
Others
(3)
Newly Affordable Stocks with Good Financials and Durability (subscription)
Consistent Highest Return Stocks over Five Years - Nifty500
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Company with high TTM EPS Growth
Strong Annual EPS Growth
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Return, Short-term Strategy with Piotroski Score, SMA and RSI (Higher Risk)
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Companies with rising net profit margins - quarterly as well as TTM basis
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
RSI indicating price strength
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Negative Breakdown First Support (LTP < S1)
Increasing Trend in Non-Core Income
High promoter stock pledges
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Big Deal (Insider and SAST) buys last month greater than 1% of total shares
Big Deal (Insider and SAST) buys last week greater than 1% of total shares
US FDA Warning Letter
High Piotroski Score - Companies with strong financials
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks